triple glp-1/gip/glucagon receptor agonist Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor
Description
doi: 10.5414/cp201462
Current guidelines from Europe6 and the United States7 recommend initiating GLP-1RAs therapy promptly after the failure of oral hypoglycemic agents, prioritizing their use over insulin therapy
Supports Healthy Pathways Associated with GLP-1 Activity
However, limited or no medical nutrition therapy (MNT) guidelines are provided to healthcare providers and patients regarding adequate nutrient intake during GLP-1RA use
Diabetes 60 , 31033109 (2011)
